TRPV1 receptor: A target for the treatment of pain, cough, airway disease and urinary incontinence

Drug News and Perspectives

Volumn 18, Issue 3, 2005, Pages 165-171

  Jia, Yanlin ^a   McLeod, Robbie L ^a   Hey, John A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMG 9810; ANANDAMIDE; CAPSAICIN; CAPSAZEPINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; LIPOXYGENASE; NGD 8695; NGV 1; NGV 2; NGV 3; PAC 20030; PROTEIN KINASE C; PROTON; RECEPTOR BLOCKING AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ACIDIFICATION; ASTHMA; BODY TEMPERATURE; CLINICAL TRIAL; COUGHING; HEAT; HUMAN; HYPERALGESIA; NEUROGENIC INFLAMMATION; NONHUMAN; PAIN; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RESPIRATORY TRACT DISEASE; REVIEW; SENSORY NERVE; SMOOTH MUSCLE CONTRACTION; URINE INCONTINENCE;

ANIMALS; ARACHIDONIC ACIDS; COUGH; HEAT; HUMANS; HYDROGEN-ION CONCENTRATION; ION CHANNELS; LIPOXYGENASE; LUNG DISEASES; PAIN; POLYUNSATURATED ALKAMIDES; TRPV CATION CHANNELS; URINARY INCONTINENCE;

EID: 18944406302     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2005.18.3.892761     Document Type: Review

References (84)

1. Thresh, L.T. Isolation of capsaicin. Pharm J 1846, 6: 941.
2. Spath E. and Darling S.F. Synthesis of capsaicin. Ber Chem Ges 1930, 63B: 737-40.
3. Toh, C.C., Lee, T.S. and Kiang, A.K. The pharmacological actions of capsaicin and analogues. Br J Pharmacol 1955, 10: 175-81.
4. Porszasz, J., Gyorgy, L. and Porszasz-Gibiszer, K. Cardiovascular and respiratory effects of capsaicin. Acta Physiol Hung 1955, 8: 61-76.
5. Szallasi, A. and Blumberg, P.M. Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res 1990, 524: 106-11.
6. Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, R.A., Levine, J.D. and Julius, D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997, 398: 816-24.
7. Szallasi, A. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol Scand 1995, 155(Suppl 629): 1-68.
8. Mezey, E., Toth, Z.E., Cortright, D.N. et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000, 97: 3655-60.
9. Szallasi, A. and Blumberg, P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51: 159-211.
10. Tominaga, M., Caterina, M.J., Malmberg, A.B. et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21: 531-43.
11. Huang, S.W., Cho, H., Kwak, J. et al. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000, 97: 6155-60.
12. Uchida, Y. and Murao, S. Acid-induced excitation of afferent cardiac sympathetic nerve fibres. Am J Physiol 1975, 228: 27-33.
13. Jacobus, W.E., Taylor, G.J., Hollis, D.P. and Nunnally, R.L. Phosphorus nuclear magnetic resonance of perfused working rat hearts. Nature 1977, 265, 756-8.
14. Steen, K.H., Steen, A.E. and Reeh, P.W. A dominant role of acid pH in inflammatory excitation and sensitization of nociception in rat skin in vitro. J Neurosci 1995, 15: 3982-9.
15. Hunt, J.F., Fanf, K., Malik, R. et al. Endogenous airway acidification implications for asthma pathophysiology. Am J Respir Crit Care Med 2000, 161: 694-9.
16. Jordt, S.E., Tominaga, M. and Julies D. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 2000, 97: 8134-9.
17. Petersen, M. and LaMotte, R.H. Effect of protons on the inward current evoked by capsaicin in isolated dorsal root ganglion cells. Pain 1993, 54: 37-42.
18. Martenson, M.E., Ingram, S.L. and Baumann, T.K. Potentiation of rabbit trigeminal responses to capsaicin in a low pH environment. Brain Research 1994, 651: 143-7.
19. Kress, M., Fetzer, S., Reeh, P. and Vyklicky, L. Low pH facilitates capsaicin responses in isolated sensory neurons of the rat. Neurosci Lett 1996, 221: 5-8.
20. McLatchie, L.M. and Bevan, S. The effects of pH on the interaction between capsaicin and the vanilloid receptor in rat dorsal root ganglia neurons. Br J Pharmacol 2001, 132: 899-908.
21. Tominaga, M., Wada, M. and Masu, M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 2001, 98: 6951-6.
22. Sugiura, T., Tominaga, M., Katsuya, H. and Mizumura, K. Bradykinin lowers the threshold temperature of heat activation of vanilloid receptor I. J Neurophysiol 2002, 88: 544-8.
23. Samuelsson, B. Leukotrienes: Mediators of immediate hyper sensitivity reactions and inflammation. Science 1983, 220: 568-75.
24. Levine, J.D., Lam, D., Taiwo, Y.O., Donatoni, P. and Goetzl E.J. Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid. Proc Natl Acad Sci USA 1986, 83: 5331-4.
25. Devane, W.A., Hanus, L., Breuer, A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258: 1946-9.
26. Di Marzo, V., Fontana, A., Cadas, H. et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372: 686-91.
27. Calignano, A., Katona, I., Desarnaud, F. et al. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 2000, 408: 96-101.
28. Zygmunt, P.M., Petersson, J., Andersson, D.A. et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400: 452-7.
29. Ralevic, V., Dendall, D.A., Jerman, J.C., Middlemiss, D.N. and Smart, D. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur J Pharmacol 2001, 424: 211-9.
30. Smart, D., Gunthorp, M.J., Jerman, J.C. et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 2000, 129: 227-30.
31. Ross, R.A. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 2003, 140: 790-801.
32. Huang, S.W., Bisogno, T. and Trevisani, M. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 2002, 8400-5.
33. Numazaki, M., Tominaga, T., Toyooka, H. and Tominaga, M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 2002, 277: 13375-8.
34. Bhave, G., Hu, H.J., Glauner, K.S. et al. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid I (TRPV1). Proc Natl Acad Sci USA 2003, 100: 12480-5.
35. Crandall, M., Kwash, J., Yu, W. and White, G. Activation of protein kinase C sensitizes human VR1 to capsaicin and to moderate decreases in pH at physiological temperatures in Xenopus oocytes. Pain 2002, 98: 109-17.
36. Vellani V., Mapplebeek S., Moriondo, A., Davis, J.B. and McNaughton, P.A. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 2001, 534: 813-25.
37. Bhave, G., Zhu, W., Wang, H., Brasier, D.J. Oxford, G.S. and Gereau, R.W., IV. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35: 721-31.
38. Hingtgen, C.M., Waite, K.J. and Vasko, M.R. Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J Neurosci 1995, 15: 5411-9.
39. Hu, H.-J., Bhave, G. and Gereau, R.W., IV. Prostaglandin and PKA-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: Potential mechanism for thermal hyperalgesia. J Neurosci 2002, 22: 7444-52.
40. Lopshire, J.C. and Nicol, G.D. The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicinelicited current in rat sensory neurons: Whole-cell and single-channel studies. J Neurosci 1998, 18: 6081-92.
41. Kwong, K. and Lee, L.Y. PGE2 sensitizes cultured pulmonary vagal sensory neurons to chemical and electrical stimuli. J Appl Physiol 2002, 93: 1419-28.
42. Manning, D.C., Raja, S.N., Meyer, R.A. and Campbell, J.N. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Ther 1991, 50: 721-9.
43. Vyklicky, L., Knotkova-Urbancova, H., Vitaskova, Z., Vlachova, V., Kress, M. and Reeh, P.W. Inflammatory mediators at acidic pH activate capsaicin receptors in cultured sensory neurons from newborn rats. J Neurophysiol 1998, 79: 670-6.
44. Ji, R.R., Samad, T.A., Jin, S.X., Schmoll, R. and Woolf, C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002, 36: 57-68.
45. Simone, D.A., Ngeow, J.Y.F., Putterman, G.J. and LaMotte, R.H. Hyperalgesia to heat after intradermal injection of capsaicin. Brain Res 1987, 418: 201-3.
46. Simone, D.A., Baumann, T.F. and LaMotte, R.H. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989, 38: 99-107.
47. Pomonis, J.D., Harrison, J.E., Mark, L., Bristol, D.R., Valenzano K.J. and Walker, K. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl) tetrahydropyrazine-I(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003, 306: 387-93.
48. Walker, K.M., Urban, L., Medhurst, S.J. et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003, 304: 56-62.
49. Kwak, J.Y., Jung, J.Y., Hwang, S.W., Lee, W.T. and Oh, U. A capsaicin-receptor antagonist, capsazepine, reduces inflammationinduced hyperalgesic responses in the rat: Evidence for an endogenous capsaicin-like substance. Neuroscience 1998, 86: 619-26.
50. Caterina, M.J., Leffler, A., Malmberg, A.B. et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288: 306-13.
51. Bernstein, J.E., Korman, N.J., Bickers, D.R., Dahl, M.V. and Millikan, L.E. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989, 21: 265-70.
52. Mathias, B.J., Dillingham, T.R., Zergler, D.N., Chang, A.S. and Belandres, P.V. Topical capsaicin for chronic neck pain. A pilot study. Am J Phys Med Rehabil 1995, 74: 39-44.
53. Ellison, N., Loprinzi, C.L., Kugler, J. et al. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncology 1997, 15: 2974-80.
54. Michael, G.J. and Priestley, J.V. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its down-regulation by axotomy. J Neurosci 1999, 19: 1844-54.
55. Szallasi, A., Goso, C. and Manzini, S. Resiniferatoxin binding to vanilloid receptors in guinea pig and human airways. Am J Respir Crit Care Med 1995, 152, 59-63.
56. Joos, G.F., Germonpre, P.R. and Pauwels R.A. Neural mechanisms in asthma. Clin Exp Allergy 2000, 30: 60-5.
57. Palmer, J.B., Cuss, F.M., Mulderry, P.K. et al. Calcitonin gene-related peptide is localized to human airway nerves and potently constricts human airway smooth muscle. Br J Pharmacol 1987, 91: 95-101.
58. Cross, L.J., Heaney, L.G. and Ennis, M. Further characterisation of substance P induced histamine release from human bronchoalveolar lavage mast cells. Inflamm Res 1996, 45(Suppl 1): S11-2.
59. Heaney, L.G., Cross, L.J. Stanford, C.F. and Ennis, M. Substance P induces histamine release from human pulmonary mast cells. Clin Exp Allergy. 1995, 25: 179-86.
60. Forsythe, P., McGarvey, L.P., Heaney, L.G., MacMahon, J. and Ennis, M. Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both non-asthmatic coughers and cough variant asthmatics. Clin Exp Allergy 2000, 30: 225-32.
61. Braman, S.S. and Carrao, W.M. Cough differential diagnosis and treatment. Clin Chest Med 1987, 8: 177-82.
62. Cherry, D.K. and Woodwell, D.A. National ambulatory medical care survey: 2000 summary. Adv Data 2002, 328: 1-32.
63. McLeod, R.L., Tulshian, D.B. and Hey, J.A. Novel pharmacological targets and progression of new antitussive drugs. Expert Opin Ther Patents 2003, 13: 1501-12.
64. Tucker, R.C., Kagaya, M., Page, C.P. and Spina, D. The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br J Pharmacol 2001, 132: 1127-35.
65. Jia, Y., McLeod, R.L., Wang, X., Parra, L.E., Egan, R.W. and Hey, J.A. Anandamide induces cough in conscious guinea pigs through VR1 receptors. Br J Pharmacol 2002, 137: 831-6.
66. Undem, B.J. and Kollarik, M. Characterization of vanilloid receptor 1 antagonist iodo-resiniferatoxin on the afferent and efferent function of vagal sensory C-fibers. J Pharmacol Exp Ther 2002, 303: 716-22.
67. Carr, M.J. and Undem, B.J. Pharmacology of vagal afferent nerve activity in guinea pig airways. Pulm Pharmacol Ther 2003, 16: 45-52.
68. Boiser, D.C., DeGennaro, F.C., O'Reilly, S., Hey, J.A. and Chapman, R.W. Pharmacological studies of allergic cough in the guinea pig. Eur J Pharmacol 1995, 277: 159-64.
69. Higenbottam, T. and Lowry, R. Adaptation and cross-adaptation of the cough reflex in response to distilled water. Capsaicin and prostaglandin E2 aerosols in man. J Physiol 1990, 422: 432.
70. Hathaway, T.J., Higenbottam, T.W., Morrison, J.F.J., Clelland, C.A. and Wallwork, J. Effects of inhaled capsaicin in heart-lung transplant patients and asthmatic subjects. Am Rev Respir Dis 1993, 148: 1233-7.
71. Dicpinigaitis, P.V. Short- and long-term reproducibility of capsaicin cough challenge testing. Pulm Pharmacol Ther 2003, 16: 61-5.
72. Doherty, M.J., Mister, R., Pearson, M.G. and Calverley, P.M.C. Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 2000, 55: 643-9.
73. Fujimura, M., Ogawa, H., Yasui, M. and Matsuda T. Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non-productive cough. Clin Exp Allergy 2000, 30: 41-7.
74. Weinfeld, D., Ternesten-Hasseus, E., Lowhagen, O. and Millqvist, E. Capsaicin cough sensitivity in allergic asthmatic patients increases during the birch pollen season. Ann Allergy Asthma Immunol 2002, 89: 419-24.
75. Apina D. Airway sensory nerves: A burning issue in asthma. Thorax 1996, 51: 335-7.
76. Manzini, S., Maggi, C.A., Geppetti, P. and Bacciarelli, C. Capsaicin desensitization protects from antigen-induced bronchospasm in conscious guinea-pigs. Eur J Pharmacol 1987, 138: 307-8.
77. Herd, C.M., Gozzard, N. and Page C.P. Capsaicin pre-treatment prevents the development of antigen-induced airway hyperresponsiveness in neonatally immunized rabbits. Eur J Pharmacol 1995, 282: 111-9.
78. Buckley, T.L. and Nijkamp, F.P. Airways hyperreactivity and cellular accumulation in a delayed-type hypersensitivity reaction in the mouse. Modulation by capsaicin-sensitive nerves. Am J Resp Crit Care Med 1994, 149; 400-7.
79. Agopyan, N., Bhatti, T., Yu, S. and Simon, S.A. Vanilloid receptor activation by 2- and 10-microm particles induces responses leading to apoptosis in human airway epithelia cells. Toxicol Appl Pharmacol 2003, 192: 21-35.
80. Yiangor, Y., Facer, P., Ford, A. et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 2001, 87: 774-9.
81. Zhang, X., Igawa, Y, Ishizuka, O., Nishizawa, O. and Andersson, K.E. Effects of resiniferatoxin desensitization of capsaicinsensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats. Naunyn-Schmiedeberg's Arch Pharmacol 2003, 367: 473-9.
82. Berder, L.A., Nakamura, Y., Kiss, Y. et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002, 5: 856-60.
83. Maggi, C.A., Giuliani, S., Santiciolo, P. et al. Species-related variations in the effects of capsaicin on urinary bladder function: Relation to bladder content of substance P-like immunoreactivity. Naunyn-Schmiedeberg's Arch Pharmacol 1987, 336: 546-55.
84. Cruz, F. Vanilloid receptor and detrusor instability. Urology 2002, 59: 51-60.